Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease cholangitis
Phenotype C0206698|cholangiocarcinoma
Sentences 10
PubMedID- 21603286 Ca19-9 was useful for predicting cholangiocarcinoma in patients with primary sclerosing cholangitis, with the sensitivity being 79%, the specificity 99%, the adjusted positive predictive value 57% and the negative predictive value 99% (49).
PubMedID- 23894567 Various cohort studies showed an increased occurrence of cholangiocarcinoma in patients with primary sclerosing cholangitis, ranging from 10% to 13% [6]–[8].
PubMedID- 25132998 Moreover, igg4-related disease is a high-risk factor for cancer development; igg4-related sclerosing cholangitis (igg4-sc) cases associated with cholangiocarcinoma or its precursor lesion biliary intraepithelial neoplasia (bilin) have been reported.
PubMedID- 25636976 Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
PubMedID- 25500329 Background: the diagnosis of cholangiocarcinoma (cca) in patients with primary sclerosing cholangitis (psc) is particularly difficult.
PubMedID- 24432227 Candida tropicalis in a case of cholangiocarcinoma with cholangitis at a tertiary care hospital in manipal.
PubMedID- 25623660 Objectives: polysomy detected by fluorescence in situ hybridization (fish) is associated with cholangiocarcinoma (cca) in patients with primary sclerosing cholangitis (psc).
PubMedID- 23007734 Background: carbohydrate antigen 19-9 (ca 19-9) is the serum marker used to diagnose cholangiocarcinoma (cca) in patients with primary sclerosing cholangitis (psc).
PubMedID- 25259419 Early diagnosis of dysplastic changes and exclusion of cholangiocarcinoma (cca) in patients with primary sclerosing cholangitis (psc) remain a major clinical challenge.
PubMedID- 21374660 Early detection of malignant biliary tract diseases, especially cholangiocarcinoma (cc) in patients with primary sclerosing cholangitis (psc), is very difficult and often comes too late to give the patient a therapeutic benefit.

Page: 1